The guidelines address diagnosis, treatment and post-therapy issues. AYA patients have lower rates of clinical trial enrollment, adequate health insurance and compliance with prescribed treatments, according to the release.
The guidelines suggest AYA patients be referred to cancer centers with expertise and experience in treating patients in this age group and their cancers. They also call for increased enrollment in clinical trials, a multidisciplinary approach to treatment and attention to the special physical and psychosocial issues of AYA patients.
More Articles on Hospital Oncology:
Mercy, Patients First Health Care in Missouri to Consolidate Cancer Services
Memorial Hermann Unveils New Cancer Center in Houston
10 Hospital Cancer Center Expansions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
